D. Ishola

R. Goldschmeding, W. Kriz, J. Joles, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols

D. Watson-Jones, D. Ishola, M. Hodges, 2022, PloS one.

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone

D. Watson-Jones, D. Ishola, E. Smout, 2022, Emerging infectious diseases.

Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children

D. Watson-Jones, Pauline Akoo, D. Ishola, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

S. Lees, D. Watson-Jones, B. Lowe, 2021, The Lancet. Infectious diseases.

The evolutionary dynamics of influenza A virus adaptation to mammalian hosts

S. Bhatt, Y. Guan, T. Lam, 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

Piloting a pragmatic clinical audit tool for quality improvement in rural paediatric care in northern Sierra Leone

D. Watson-Jones, D. Ishola, P. Ayieko, 2023, medRxiv.

"We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.

S. Lees, D. Watson-Jones, H. Larson, 2018, Social science & medicine.

Could influenza transmission be reduced by restricting mass gatherings? Towards an evidence-based policy framework

D. Ishola, David A. Ishola, Nick Phin, 2011, Journal of Epidemiology and Global Health.

An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.

F. Arogundade, D. Ishola, A. Sanusi, 2005, African journal of medicine and medical sciences.

Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs

D. Ishola, A. Ajayi, A. Q. Adigun, 2003, Journal of Human Hypertension.

Influenza vaccination for immunocompromised patients: summary of a systematic review and meta‐analysis

F. Greaves, C. Beck, J. Nguyen-Van-Tam, 2013, Influenza and other respiratory viruses.

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

P. Easterbrook, N. French, H. Namata, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased risk of A(H1N1)pdm09 influenza infection in UK pig industry workers compared to a general population cohort

I. Brown, J. Nguyen-Van-Tam, A. Hayward, 2016, Influenza and other respiratory viruses.

P1-180 Could influenza transmission be reduced by restricting mass gatherings? An evidence review

D. Ishola, N. Phin, 2011, Journal of Epidemiology and Community Health.

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen

D. Watson-Jones, C. Drakeley, S. Soremekun, 2023, Vaccines.

What factors are associated with paediatric admissions and their outcomes in a rural hospital in northern Sierra Leone? Insights from a pilot observational study

D. Ishola, G. Deen, D. Kowuor, 2023, BMJ Public Health.

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.

D. Watson-Jones, E. D’Ortenzio, D. Ishola, 2023, The Lancet. Global health.

"We are the heroes because we are ready to die for this country": Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial.

S. Lees, D. Watson-Jones, H. Larson, 2018, Social science & medicine.

country ” : Participants' decision-making and grounded ethics in an Ebola vaccine clinical trial

D. Ishola, E. Smout, Thomas Mooney, 2022 .